BioInvent International AB - Asset Resilience Ratio

Latest as of June 2025: 42.92%

BioInvent International AB (BINV) has an Asset Resilience Ratio of 42.92% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr393.47 Million

Cash + Short-term Investments

Total Assets

Skr916.67 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how BioInvent International AB's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down BioInvent International AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr393.47 Million	42.92%
Total Liquid Assets	Skr393.47 Million	42.92%

Asset Resilience Insights

Very High Liquidity: BioInvent International AB maintains exceptional liquid asset reserves at 42.92% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

BioInvent International AB Industry Peers by Asset Resilience Ratio

Compare BioInvent International AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
MedPacto Inc KQ:235980	Biotechnology	49.82%
Shenzhen CAU Technology Co Ltd SHE:000004	Biotechnology	6.20%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	6.88%
Nanhua Bio Medicine Co Ltd SHE:000504	Biotechnology	11.93%
Jiangsu Sihuan Bioengineering Co Ltd SHE:000518	Biotechnology	0.03%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%
Hualan Biological EngineeringInc SHE:002007	Biotechnology	14.68%

Annual Asset Resilience Ratio for BioInvent International AB (2000–2024)

The table below shows the annual Asset Resilience Ratio data for BioInvent International AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	43.70%	Skr432.33 Million	Skr989.24 Million	-14.09pp
2023-12-31	57.79%	Skr809.15 Million	Skr1.40 Billion	+28.44pp
2022-12-31	29.34%	Skr502.43 Million	Skr1.71 Billion	+17.45pp
2021-12-31	11.89%	Skr172.07 Million	Skr1.45 Billion	-5.79pp
2017-12-31	17.68%	Skr30.06 Million	Skr170.05 Million	-32.29pp
2014-12-31	49.97%	Skr37.03 Million	Skr74.11 Million	-11.52pp
2013-12-31	61.49%	Skr50.07 Million	Skr81.44 Million	-6.59pp
2012-12-31	68.07%	Skr79.34 Million	Skr116.54 Million	+28.41pp
2011-12-31	39.67%	Skr81.62 Million	Skr205.76 Million	-10.41pp
2010-12-31	50.07%	Skr69.12 Million	Skr138.03 Million	+42.17pp
2009-12-31	7.91%	Skr9.98 Million	Skr126.25 Million	-46.65pp
2008-12-31	54.56%	Skr161.18 Million	Skr295.43 Million	-2.40pp
2007-12-31	56.96%	Skr154.37 Million	Skr271.00 Million	+43.51pp
2006-12-31	13.45%	Skr19.96 Million	Skr148.33 Million	-8.99pp
2005-12-31	22.45%	Skr59.78 Million	Skr266.34 Million	+17.18pp
2000-12-31	5.27%	Skr10.23 Million	Skr194.26 Million	--

pp = percentage points

About BioInvent International AB

ST:BINV Sweden Biotechnology

Market Cap

$158.27 Million

Skr1.47 Billion SEK

Market Cap Rank

#18893 Global

#273 in Sweden

Share Price

Skr22.35

Change (1 day)

-1.54%

52-Week Range

Skr21.60 - Skr41.05

All Time High

Skr95.26